Electra Therapeutics SEC Filings
NASDAQ: ETRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
9.04-0.10 (-1.09%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Electra Therapeutics filing overview
This page lists 13 recent SEC filings by Electra Therapeutics (ETRA), including 6 4, 2 SCHEDULE 13G, 1 SCHEDULE 13D, 1 8-K. The latest current report (8-K), used to disclose material events such as earnings releases and executive changes, was filed on Sep 21, 2026. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
ETRA SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Sep 28, 2026 | SCHEDULE 13G | Beneficial ownership report (passive) | View on EDGAR |
| Sep 28, 2026 | SCHEDULE 13G | Beneficial ownership report (passive) | View on EDGAR |
| Sep 25, 2026 | SCHEDULE 13D | Beneficial ownership report (activist) | View on EDGAR |
| Sep 23, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 23, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 21, 2026 | 8-K | Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Other Events | View on EDGAR |
| Sep 21, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 21, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 21, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 21, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 18, 2026 | 424B4 | Prospectus | View on EDGAR |
| Sep 14, 2026 | S-1/A | Registration statement (amendment) | View on EDGAR |
| Aug 28, 2026 | S-1 | Registration statement | View on EDGAR |